Cancer Risk Equipment
-
Manufactured by IceCure Medical Ltdbased in ISRAEL
, low-risk, early-stage malignant breast tumors without subsequently removing them. The trial began in 2014 and has completed recruitment of 206 patients in 19 hospitals and medical centers across the US, including Columbia University Medical Center and Mount Sinai Beth ...
-
Manufactured by Therawisbased in GERMANY
Personalized medicine aims to identify patients who require treatment and subsequently select the right therapy based on individual factors and tumor characteristics, i.e. personalized medicine targets to identify the right patients for the right therapy. Prognostic biomarkers provide information on the risk of disease recurrence ...
-
Manufactured by Olympia Diagnostics, Inc.based in USA
A diagnostic test kit quantitatively measures the expression levels of a panel of prostate cancer risk-associated biomarkers in patient urine sample or biopsy tissue sample to distinguish high-risk and aggressive prostate cancer needing immediate treatment from low-risk and indolent prostate ...
-
based in USA
tissue. This increases the risk of cancerous cells being left behind, contributing to bladder cancer’s more than 50% recurrence rate ...
-
Manufactured by Spark Mobile Diagnosticsbased in INDIA
Lateral flow “Sandwich” Assay with technology developed by US experts in industry; Detects both Vitamin D2 and D3 in range of 4 ng/ml – 100 ng/ml; High specificity – No Interference of Biotin; Ideal screening test for Physicians clinics, OB/GYN, Orthopedics and general wellness ...
-
Manufactured by ORYX GmbH & Co. KGbased in GERMANY
The human cyclin-dependent kinase inhibitor p16INK4a is a tumor antigen expressed in various cancers, including lung and breast cancer. In normal cells, p16INK4a is rarely expressed and leads to immediate senescence. In all cancers associated with high risk human papilloma virus (HR-HPV), p16INK4a is constantly expressed as an ...
-
Manufactured by Time Medical Holdingbased in CHINA
The EMMA 1.5T MRI is designed to offer breast imaging centers a new adjunctive tool to their current equipment options. Emma is a whole body MRI with dedicated breast coils for exclusive high-quality imaging. In collaboration with leading breast cancer centers and following new published trends, the EMMA system extends MRI's strong ...
-
Manufactured by Xi’an Ruisaen Biotechnology Co., Ltd.based in CHINA
Vitamin D3 or cholecalciferol, is a type of vitamin D which is made by the skin when exposed to sunlight, it also found in some foods and can be taken as a dietary supplement. Cholecalciferol is made in the skin following UVB light exposure. It is converted in the liver to calcifediol (25-hydroxyvitamin D) which is then converted in the kidney to calcitriol (1,25-dihydroxyvitamin D). One of its ...
-
Manufactured by GENCURIXbased in SOUTH KOREA
Multigene prognostic test predicts the probability of metastasis or recurrence, which helps patients make treatment decision. It improves quality of life for cancer patients as preventing them from unnecessary ...
-
by Natera, Inc.based in USA
Empower is a genetic test for those who want to know more about their risk of developing cancer, why it might be common in their family, or want to inform treatment options following a cancer diagnosis. Empower screens for genes associated with increased risk for common hereditary cancers. Our Empower ...
-
Manufactured by PreludeDxbased in USA
Predicts radiation benefit. DCISionRT is the only test capable of predicting an individual patient’s benefit from radiation therapy. Using DCISionRT provides you with 10-year Total and Invasive Recurrence Risk after breast conserving surgery as well as surgery with radiation therapy. No other test can do ...
-
Manufactured by Xi’an Ruisaen Biotechnology Co., Ltd.based in CHINA
A structure similar to glucose, vitamin C is a kind of polyol, 2 and 3 in the molecular of two adjacent enol hydroxyl easy to disintegrate and release H +, the reason is the nature of the acid, also known as ascorbic acid. Vitamin C has strong reducibility, is easy to be oxidized to dehydrogenation vitamin C, but the reaction is reversible, and ascorbic acid and dehydrogenation ascorbic acid has ...
-
Manufactured by Nucleix Ltd.based in USA
Bladder cancer is the 5th most common cancer in the western world, and 70%-80% of the patients are diagnosed with non-muscle invasive disease. There are estimated 400,000 to 800,000 active bladder cancer patients in the United States, as well as 1 to 2 million in Europe, who undergo local resection of the tumor and then have 1-4 follow-up ...
-
Manufactured by Veracytebased in FRANCE
Immunoscore® for Rectal Cancer can help identify patients with LARC who are at a low risk of relapse and may be good candidates for organ preservation. Immunoscore® is available through an Innovation Access Program while the company conducts clinical validation ...
-
Manufactured by Mesothelioma + Asbestos Awareness Centerbased in USA
Lung cancer is one of the most common cancers, and researchers estimate about 3 – 4% of all cases can be attributed to asbestos ...
-
Manufactured by Cysview, Trademark of Photocurebased in USA
Historically, bladder cancer patients are at high risk for disease recurrence and progression,1 which could be due in part to missed tumors and incomplete surgeries because not all cancerous tissue is easy to see under white light. Moving forward, with the availability of Blue Light Cystoscopy with Cysview, that trend may ...
-
Manufactured by MD Diagnostics Ltdbased in CANADA
Dental professionals have a unique opportunity to address smoking with patients in a manner that will make a difference. Brief advice from a dentist or member of the dental team has been shown to increase a patient’s motivation to quit and can double a patient’s success with ...
-
Manufactured by Amadixbased in SPAIN
It can also be used as a tool for a high-risk screening population in combination with Low Dose Computed Tomography (LDCT). DiagnoLung identifies and measures proteins which are differentially expressed in blood samples of individuals with Lung ...
-
Manufactured by Rhythm Biosciences Limitedbased in AUSTRALIA
The ColoSTAT technology has the potential to become the new, first step screening test for people, who for personal, cultural or clinical reasons, elect to not participate in the existing screening programs for colorectal ...
-
Manufactured by Newmars Technologies Ltd.based in HUNGARY
Cervical Cancer is the 2nd most common cancer afflicting women worldwide [1]. In many countries, cervical cancer screening programs utilize a Pap test. If the Pap result is abnormal a visual examination called colposcopy, and in many instances one or more biopsies of the cervix is preformed to detect abnormal cervical tissue. ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you